Sphera Funds Management Ltd. Prothena Corp Public LTD CO Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 10, 2018
SELL
$27.95 - $45.04 $5.73 Million - $9.23 Million
-205,000 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$35.44 - $63.76 $5.14 Million - $9.25 Million
145,000 Added 241.67%
205,000 $7.69 Million
Q3 2017

Nov 09, 2017
BUY
$53.83 - $67.75 $3.23 Million - $4.07 Million
60,000
60,000 $3.89 Million

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $723M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email